Status | Study |
RECRUITING |
Study Name: A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin Condition: Growth Hormone Deficiency Date: 2023-03-08 Interventions: No intervention |
RECRUITING |
Study Name: A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA Condition: Growth Hormone Deficiency Date: 2023-03-07 Interventions: No intervention |
Completed |
Study Name: Isolated Growth Hormone Deficiency and Amennorrhea Condition: Growth Hormone Deficiency Date: 2022-06-26 Interventions: Diagnostic Test: Hormone panel testsPatient was subjected to a battery of hormone tests, including FSH, LH, estrogen, progesterone and growth ho |
Recruiting |
Study Name: A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency Condition: Growth Hormone Deficiency Date: 2017-04-05 Interventions: Drug: Somavaratan All subjects will receive somavaratan 3.5 mg/kg twice monthly (every 15 days ± 2 |
Completed |
Study Name: Diagnosing Adult Growth Hormone Deficiency Condition: Growth Hormone Deficiency Date: 2017-01-06 Interventions: Other: GHRH plus arginine test One ug/kg GHRH [GHRH(1-29), GEREF Serono, Italy] was administered as an i |
Recruiting |
Study Name: Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency Condition: Growth Hormone Deficiency Date: 2016-11-24 Interventions: Biological: Jintropin AQ Jintropin AQ, injection, 30IU/10 mg/3ml/kit, 0.25mg /kg/w, once per day for 26 |
Recruiting |
Study Name: Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency Condition: Growth Hormone Deficiency Date: 2016-09-19 Interventions: Drug: PEG-somatropin High dose group: PEG Somatropin 0.2 mg/kg/w, subcutaneous use, inject once a week, |
Completed |
Study Name: Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency Condition: Growth Hormone Deficiency Date: 2016-01-19 Interventions: Drug: somatropin Subcutaneous |
Completed |
Study Name: Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency Condition: Growth Hormone Deficiency With Pituitary Anomalies Date: 2015-09-21 Interventions: Drug: Macimorelin macimorelin |
Completed |
Study Name: Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD) Condition: Growth Hormone Deficiency Date: 2015-06-03 Interventions: Drug: Growth Hormone-Releasing Hormone From Baseline Visit (T0) to 6th Month Visit 0,025 mg/kg Growth Ho |